IP Verse

Hanmi Pharm competitive analysis

Latest publications and patents of Hanmi Pharm New

Explore the latest publications and patents granted to Hanmi Pharm, showcasing their recent innovations and technological advancements.

Last updated on: Sep 27, 2025

Publication Number	Publication Date	Title	Legal Status
Get instant update for new patents of Hanmi Pharm
EP3421034	Nov 16, 2022	Composite Capsule Preparation Containing Tadalafil And Tamsulosin And Having Improved Stability And Elution Rate	Revoked
EP2877201	Jun 5, 2019	A Liquid Formulation Of Long-Acting Insulin And Insulinotropic Peptide	Granted And Under Opposition

Latest patents of Hanmi Pharm opposed by its competitors

Explore Hanmi Pharm's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Oct 2, 2025

Patent Number	Grant Date	Title	Total Oppositions
EP3421034	Nov 16, 2022	Composite Capsule Preparation Containing Tadalafil And Tamsulosin And Having Improved Stability And Elution Rate	1
EP2877201	Jun 5, 2019	A Liquid Formulation Of Long-Acting Insulin And Insulinotropic Peptide	1

Latest PTAB cases involving Hanmi Pharm

Discover the latest PTAB cases involving Hanmi Pharm, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Hanmi Pharm with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Oct 2, 2025

Company	Oppositions Filed	Oppositions Faced	PTAB Cases Filed	PTAB Cases Faced	Strategy Type
HANMI PHARM	-	2	-	-	Non-Active
GENERICS UK	212	-	-	-	Highly Aggressive
JAMES POOLE	151	-	-	-	Highly Aggressive